Temasek Holdings Private Ltd bought a new position in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 1,330,515 shares of the company's stock, valued at approximately $99,922,000. Temasek Holdings Private Ltd owned approximately 0.29% of GE HealthCare Technologies at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also bought and sold shares of the business. Brown Brothers Harriman & Co. lifted its holdings in shares of GE HealthCare Technologies by 4.6% in the 3rd quarter. Brown Brothers Harriman & Co. now owns 4,279 shares of the company's stock worth $321,000 after acquiring an additional 189 shares during the last quarter. Banque Transatlantique SA grew its holdings in shares of GE HealthCare Technologies by 208.3% during the 3rd quarter. Banque Transatlantique SA now owns 2,084 shares of the company's stock valued at $156,000 after purchasing an additional 1,408 shares during the last quarter. Dodge & Cox grew its holdings in shares of GE HealthCare Technologies by 16.8% during the 3rd quarter. Dodge & Cox now owns 27,517,311 shares of the company's stock valued at $2,066,550,000 after purchasing an additional 3,949,361 shares during the last quarter. EHP Funds Inc. purchased a new position in GE HealthCare Technologies in the 3rd quarter worth $225,000. Finally, Glenmede Investment Management LP lifted its stake in GE HealthCare Technologies by 16.1% in the third quarter. Glenmede Investment Management LP now owns 22,501 shares of the company's stock worth $1,690,000 after purchasing an additional 3,125 shares during the last quarter. 82.06% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
Several analysts have issued reports on GEHC shares. Weiss Ratings restated a "hold (c+)" rating on shares of GE HealthCare Technologies in a research report on Monday, December 29th. Piper Sandler lifted their price objective on GE HealthCare Technologies from $91.00 to $94.00 and gave the stock an "overweight" rating in a report on Friday, January 30th. Barclays boosted their target price on GE HealthCare Technologies from $86.00 to $87.00 and gave the company an "equal weight" rating in a research note on Friday, February 6th. Bank of America raised their price target on GE HealthCare Technologies from $82.00 to $92.00 and gave the stock a "neutral" rating in a research report on Monday, January 5th. Finally, Stifel Nicolaus lifted their price target on GE HealthCare Technologies from $95.00 to $98.00 and gave the stock a "buy" rating in a research note on Wednesday, February 4th. Seven equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $92.17.
View Our Latest Analysis on GE HealthCare Technologies
GE HealthCare Technologies Price Performance
Shares of GE HealthCare Technologies stock opened at $70.77 on Friday. The company's fifty day simple moving average is $80.78 and its two-hundred day simple moving average is $78.48. GE HealthCare Technologies Inc. has a 12-month low of $57.65 and a 12-month high of $89.77. The firm has a market cap of $32.25 billion, a PE ratio of 15.52, a price-to-earnings-growth ratio of 1.55 and a beta of 1.03. The company has a quick ratio of 1.13, a current ratio of 1.37 and a debt-to-equity ratio of 0.91.
GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its quarterly earnings data on Wednesday, February 4th. The company reported $1.44 EPS for the quarter, beating the consensus estimate of $1.40 by $0.04. The firm had revenue of $5.70 billion during the quarter, compared to the consensus estimate of $5.60 billion. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The company's quarterly revenue was up 7.1% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.45 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. As a group, equities analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.
GE HealthCare Technologies Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be given a dividend of $0.035 per share. The ex-dividend date of this dividend is Thursday, April 2nd. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies's dividend payout ratio is presently 3.07%.
About GE HealthCare Technologies
(
Free Report)
GE HealthCare Technologies NASDAQ: GEHC is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.
In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider GE HealthCare Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GE HealthCare Technologies wasn't on the list.
While GE HealthCare Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.